EcoDrugPlus

Prostaglandin G/h Synthase 2

Ensembl ID : ENSIPUG00000001192
Gene Symbol: LOC108277762
3 Cross references
162 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSIPUG00000021710
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSIPUG00000017887
Gene Symbol: PTGS1
4 Cross references
212 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSIPUG00000023922
Gene Symbol: PTGS2B
4 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSIPUG00000007063
Gene Symbol: PSMA1
2 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2a

Ensembl ID : ENSIPUG00000022608
Gene Symbol: PSMA2A
2 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 2b

Ensembl ID : ENSIPUG00000022346
Gene Symbol: PSMA2B
2 Cross references
267 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSIPUG00000002025
Gene Symbol: PSMA3
2 Cross references
238 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSIPUG00000014113
Gene Symbol: PSMA4
3 Cross references
186 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSIPUG00000022043
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6a

Ensembl ID : ENSIPUG00000012570
Gene Symbol: PSMA6A
3 Cross references
244 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSIPUG00000014998
Gene Symbol: PSMA6B
3 Cross references
278 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).